Related Experiment Videos
Management strategy for fetal tachycardia
1The Heart Institute for Children, Department of Pediatrics, Hope Children's Hospital, Oak Lawn, Illinois, USA.
Obstetrics and Gynecology
|September 27, 2000
Summary
A new management strategy for fetal tachycardia significantly reduced perinatal mortality and morbidity. This approach, based on tachycardia duration and heart failure severity, ensures better fetal outcomes.
Area of Science:
- Perinatology
- Fetal Cardiology
- Maternal-Fetal Medicine
Background:
- Fetal tachycardia poses risks to fetal well-being.
- Effective management strategies are crucial for improving perinatal outcomes.
Purpose of the Study:
- To develop and evaluate a management strategy for fetal tachycardia.
- To reduce perinatal mortality and morbidity associated with fetal tachycardia.
Main Methods:
- Forty-four fetuses with nonsinus tachycardia were classified into groups based on tachycardia duration and heart failure severity.
- Treatment involved expectant management, transplacental antiarrhythmic agents, or direct intramuscular therapy.
- Fetal well-being was monitored using echocardiography, ultrasound, and heart rate surveillance.
Main Results:
- Fifteen fetuses with intermittent tachycardia showed no progression.
- Sustained tachycardia with mild-to-moderate heart failure was managed with transplacental agents or elective delivery.
- Severe heart failure cases required combined intramuscular and transplacental therapy, with a 4.3-day mean cardioversion time.
- Overall, 43 of 44 fetuses were delivered with minimal morbidity and a 2.2% mortality rate.
Conclusions:
- A management strategy tailored to tachycardia duration and heart failure degree is effective.
- Vigilant fetal surveillance is key to successful management.
- This approach significantly lowers perinatal mortality and morbidity.